Cargando…
Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556447/ https://www.ncbi.nlm.nih.gov/pubmed/33052972 http://dx.doi.org/10.1371/journal.pone.0240965 |
| _version_ | 1783594218406543360 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7556447 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75564472020-10-21 Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection PLoS One Expression of Concern Public Library of Science 2020-10-14 /pmc/articles/PMC7556447/ /pubmed/33052972 http://dx.doi.org/10.1371/journal.pone.0240965 Text en © 2020 The PLOS ONE Editors http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Expression of Concern Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| title | Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| title_full | Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| title_fullStr | Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| title_full_unstemmed | Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| title_short | Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection |
| title_sort | expression of concern: vitamin d sufficiency, a serum 25-hydroxyvitamin d at least 30 ng/ml reduced risk for adverse clinical outcomes in patients with covid-19 infection |
| topic | Expression of Concern |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556447/ https://www.ncbi.nlm.nih.gov/pubmed/33052972 http://dx.doi.org/10.1371/journal.pone.0240965 |
| work_keys_str_mv | AT expressionofconcernvitamindsufficiencyaserum25hydroxyvitamindatleast30ngmlreducedriskforadverseclinicaloutcomesinpatientswithcovid19infection |